Your Health, We Care
Avatrombopag is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.
Avatrombopag is indicated for the treatment of thrombocytopenia in adult patients with chronic immunethrombocytopenia who have had an insufficient response to a previous treatment.
from FDA，2021.06
Avatrombopag is a novel oral thrombopoietin receptor agonist that has demonstrated significant efficacy in clinical application and provides a new treatment option for specific pat···【more】
Article source：Lucius LaosRelease date：2025-01-17Recommended：134
Avatrombopag is an innovative drug that plays an important role in clinical treatment, especially for patients with specific diseases.What diseases is avatrombopag suitable for?Ava···【more】
Article source：Lucius LaosRelease date：2025-01-17Recommended：141
Avatrombopag is a novel drug that has demonstrated unique therapeutic potential in specific medical areas.What are the indications for avatrombopagExploring the indications for ava···【more】
Article source：Lucius LaosRelease date：2025-01-17Recommended：106
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
